As the GLP-1 weight-loss drug market continues to grow, consumers weary of needles now have two options in pill form instead. Eli Lilly, the makers of Zepbound, gained FDA approval for its drug orforglipron, sold under the brand name Foundayo, on April 1, 2026, following Novo Nordisk, which received approval for the Wegovy pill in December 2025. Unlike the injectable forms of the drugs…
Global stock markets have been under pressure as geopolitical tensions have resurfaced in the Middle East. Moreover, investors remain concerned...
Get ready to pay more for your water. A lot more. In some parts of the U.S., mainly in the...
There’s nothing worse than waking up in a puddle of your own sweat when you are supposed to be dreaming...
When considering a Caribbean vacation, there are so many destinations, including St. Kitts and Nevis, the British and U.S. Virgin...
If there’s one thing Americans fear more than death, it might be outliving their savings. That’s one finding from an...
A cyclospora outbreak has sickened hundreds, possibly thousands, of Americans with a long-lasting parasitic infection, and dining out presents a...
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.
